RSS-Feed abonnieren

DOI: 10.1055/s-0045-1811706
Association Between Steady-State Lactate Dehydrogenase Levels and Sickle Cell Complications: A Systematic Review
Authors

Abstract
Sickle cell disease (SCD) is a hereditary hemoglobin disorder characterized by vaso-occlusion and chronic hemolysis, leading to severe complications. Finding cost-effective and reliable biomarkers for predicting disease severity and identifying high-risk patients remains challenging, especially in resource-limited settings. This systematic review evaluates the association between lactate dehydrogenase (LDH) levels measured during clinical steady-state and various complications of SCD to assess its prognostic value. A systematic literature search, adhering to PRISMA guidelines, was conducted across Medline/PubMed, Web of Science, Embase, and ScienceDirect. Eligible studies included all observational studies examining the relationship between LDH levels and subsequent SCD complications. The statistical analyses were performed to calculate the pooled standardized mean difference (SMD) and its 95% confidence interval (CI). A total of 34 studies were included, highlighting significant associations between elevated LDH levels and various SCD-related complications. These included pulmonary arterial hypertension (SMD = 0.454, 95% CI: 0.032–0.875, p = 0.035), stroke risk through transcranial Doppler velocities (SMD = 0.651, 95% CI: 0.459–0.843, p < 0.001), and kidney involvement (SMD = 0.399, 95% CI: 0.014–0.785, p = 0.042). This systematic review reveals a consistent association between elevated steady-state LDH levels and major complications of SCD. The findings suggest a potential role for LDH as a readily available biomarker for SCD severity, underlining its potential for inclusion in clinical assessments of SCD severity, risk stratification, and tailored interventions for high-risk patients.
Publikationsverlauf
Artikel online veröffentlicht:
26. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010; 376 (9757) 2018-2031
- 2 Elendu C, Amaechi DC, Alakwe-Ojimba CE. et al. Understanding sickle cell disease: causes, symptoms, and treatment options. Medicine (Baltimore) 2023; Sep 22; 102 (38) e35237
- 3 Rossi M, Belinga S, Tolo A. et al. Determinants of the haemoglobin level in patients with sickle cell disease living in sub-Saharan Africa: major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis. Br J Haematol 2024; 205 (02) 664-673
- 4 Ranque B, Thiam MM, Diallo DA. et al. Sickle cell disease glomerulopathy in five sub-Saharan African countries: results of the Cadre Study. Blood 2013; 122 (21) 779-779
- 5 Ranque B, Diaw M, Dembele AK. et al. Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study). Br J Haematol 2023; 203 (02) 319-326
- 6 Stankovic Stojanovic K, Lionnet F. Lactate dehydrogenase in sickle cell disease. Clin Chim Acta 2016; 458: 99-102
- 7 Gardner K, Thein SL. Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease. Am J Hematol 2015; 90 (10) E206-E207
- 8 Mikobi TM, Lukusa Tshilobo P, Aloni MN. et al. Correlation between the lactate dehydrogenase levels with laboratory variables in the clinical severity of sickle cell anemia in Congolese patients. PLoS One 2015; 10 (05) e0123568
- 9 Koopmans JG, van der Zee JS, Krop EJM, Lopuhaä CE, Jansen HM, Batenburg JJ. Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy 2004; 34 (12) 1827-1833
- 10 Ryu SY, Kleine CE, Hsiung JT. et al. Association of lactate dehydrogenase with mortality in incident hemodialysis patients. Nephrol Dial Transplant 2021; 36 (04) 704-712
- 11 Agrawal A, Gandhe MB, Gupta D, Reddy MV. Preliminary study on serum lactate dehydrogenase (LDH)-prognostic biomarker in carcinoma breast. J Clin Diagn Res 2016; 10 (03) BC06-BC08
- 12 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62 (10) e1-e34
- 13 Adekile AD, Azab AF, Owayed A, Khadadah M. Correlates of pulmonary function in children with sickle cell disease and elevated fetal hemoglobin. Med Princ Pract 2018; 27 (01) 49-54
- 14 Aol PM, Fahdil G, Bongomin F. et al. Prevalence, patterns, and factors associated with abnormal lung function among children with sickle cell disease in Uganda: a cross-sectional study. BMC Pediatr 2024; 24 (01) 516
- 15 Akgül F, Yalçin F, Seyfeli E. et al. Pulmonary hypertension in sickle-cell disease: comorbidities and echocardiographic findings. Acta Haematol 2007; 118 (01) 53-60
- 16 Al-Allawi N, Mohammad AM, Jamal S. Doppler-defined pulmonary hypertension in sickle cell anemia in Kurdistan, Iraq. PLoS One 2016; 11 (09) e0162036
- 17 Ataga KI, Moore CG, Jones S. et al. Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 2006; 134 (01) 109-115
- 18 Dahoui HA, Hayek MN, Nietert PJ. et al. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer 2010; 54 (03) 398-402
- 19 Dosunmu AO, Balogun TM, Adeyeye OO. et al. Prevalence of pulmonary hypertension in sickle cell anaemia patients of a tertiary hospital in Nigeria. Niger Med J 2014; 55 (02) 161-165
- 20 Liem RI, Young LT, Thompson AA. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica 2007; 92 (11) 1549-1552
- 21 Lobo CLDC, do Nascimento EM, Abelha R. et al. Risk factors of pulmonary hypertension in Brazilian patients with sickle cell anemia. PLoS One 2015; 10 (09) e0137539
- 22 Minniti CP, Sable C, Campbell A. et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica 2009; 94 (03) 340-347
- 23 Sokunbi OJ, Ekure EN, Temiye EO, Anyanwu R, Okoromah CAN. Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria. PLoS One 2017; 12 (09) e0184287
- 24 Seixas MO, Rocha LC, Carvalho MB. et al. Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease. Lipids Health Dis 2010; 9 (01) 91
- 25 Zorca SM, Freeman LA, Littel PL, Kato GJ. Hypocholesterolemia in a large sickle cell cohort: correlations of serum lipids to markers of intravascular hemolysis and vascular dysfunction. Blood 2008; 112 (11) 123-123
- 26 Aleluia MM, da Guarda CC, Santiago RP. et al. Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia. Lipids Health Dis 2017; 16 (01) 74
- 27 Pereira Gomes IC, Costa Machado Teles JP, Sousa Coelho AC. et al. Lipid profile, nutritional status and severity biomarkers in adults with sickle cell anemia. Plasmatology 2023; 17: 26 348535231193889
- 28 Valente-Frossard TNS, Cruz NRC, Ferreira FO. et al. Polymorphisms in genes that affect the variation of lipid levels in a Brazilian pediatric population with sickle cell disease: rs662799 APOA5 and rs964184 ZPR1. Blood Cells Mol Dis 2020; 80: 102376
- 29 Adegoke SA, Braga JAP, Adekile AD, Figueiredo MS. The association of serum 25-hydroxyvitamin D with biomarkers of hemolysis in pediatric patients with sickle cell disease. J Pediatr Hematol Oncol 2018; 40 (02) 159-162
- 30 Hamdy M, Salama N, Maher G, Elrefaee A. Vitamin D and nonskeletal complications among Egyptian sickle cell disease patients. Adv Hematol 2018; 2018: 3867283
- 31 Bernaudin F, Verlhac S, Coïc L. et al. High LDH level, G6PD deficiency and absence of alpha-thalassemia are significant independent risk factors of abnormally high cerebral velocities in patients with sickle cell anemia. Blood 2007; 110 (11) 430-430
- 32 Ojewunmi OO, Adeyemo TA, Osuntoki AA, Imaga NA, Oyetunji AI. Haemoglobin oxygen saturation, leucocyte count and lactate dehydrogenase are predictors of elevated cerebral blood flow velocity in Nigerian children with sickle cell anaemia. Paediatr Int Child Health 2018; 38 (01) 34-39
- 33 Adanho CSA, Yahouédéhou SCMA, Santana SS. et al. Association of laboratory markers and cerebral blood flow among sickle cell anemia children. Front Pediatr 2022; 10: 914466
- 34 Ismail A, Yusuf AA, Kuliya-Gwarzo A, Ahmed SG, Tabari AM, Abubakar SA. Correlating transcranial arterial Doppler velocities with haematologic parameters and haemolytic indices of Nigerian children with sickle cell anaemia. Ultrasound 2019; 27 (02) 101-110
- 35 Noubouossie DCF, Lê PQ, Rozen L. et al. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment. Eur J Haematol 2013; 91 (01) 46-54
- 36 Silva M, Vargas S, Coelho A. et al. Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia. Blood Cells Mol Dis 2020; Jul; 83: 102436
- 37 Domingos IF, Falcão DA, Hatzlhofer BL. et al. Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia. Ann Hematol 2014; Jul; 93 (07) 1123-1129
- 38 Gurkan S, Scarponi KJ, Hotchkiss H, Savage B, Drachtman R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr Nephrol 2010; 25 (10) 2123-2127
- 39 Day TG, Drasar ER, Fulford T, Sharpe CC, Thein SL. Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica 2012; 97 (02) 201-205
- 40 Hamideh D, Raj V, Harrington T. et al. Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia. Pediatr Nephrol 2014; 29 (10) 1997-2003
- 41 Itokua KE, Makulo JR, Lepira FB. et al. Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia. BMC Nephrol 2016; 17 (01) 178
- 42 Youssry I, Makar S, Fawzy R. et al. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1). Pediatr Nephrol 2015; 30 (12) 2163-2168
- 43 Roger C, Lionnet F, Mattioni S. et al. Risk factors for CKD stage II onset in a prospective cohort of homozygous sickle cell adults. Am J Hematol 2021; 96 (09) 1147-1155
- 44 Connes P, Lamarre Y, Hardy-Dessources MD. et al. Decreased hematocrit-to-viscosity ratio and increased lactate dehydrogenase level in patients with sickle cell anemia and recurrent leg ulcers. PLoS One 2013; 8 (11) e79680
- 45 Cumming V, King L, Fraser R, Serjeant G, Reid M. Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br J Haematol 2008; 142 (01) 119-125
- 46 Senet P, Blas-Chatelain C, Levy P. et al. Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study. Br J Dermatol 2017; 177 (01) 206-211
- 47 Garadah TS, Hassan AB, Jaradat AA. et al. Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease. Clin Med Insights Endocrinol Diabetes 2015; 8: 35-40
- 48 Fares S, Hajjar S, Romana M. et al. Sickle cell maculopathy: microstructural analysis using OCTA and identification of genetic, systemic, and biological risk factors. Am J Ophthalmol 2021; 224: 7-17
- 49 Taylor VI JG, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, Steinberg MH. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008; 3 (05) e2095
- 50 Mekontso Dessap A, Deux JF, Abidi N. et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 2011; 184 (09) 1022-1029
- 51 Feugray G, Dumesnil C, Grall M, Benhamou Y, Girot H, Fettig J. et al. OPEN Lactate dehydrogenase. Sci Rep 2023; 13 (01) 21198
- 52 Alzahri MS, Mousa SA, Almomen AM, Hasanato RM, Polimeni JM, Racz MJ. Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease. Saudi J Kidney Dis Transpl 2015; 26 (06) 1161-1168